Hawkins (NASDAQ:HWKN) Price Target Raised to $200.00 at BWS Financial

Key Points

• BWS Financial has raised its price target for Hawkins (NASDAQ:HWKN) from $160.00 to $200.00, indicating a potential upside of 25.07% from the current stock price, while maintaining a "buy" rating.
• Hawkins reported quarterly earnings of $1.40 per share, surpassing analysts’ expectations, with revenues of $293.27 million, which also exceeded projections.
• Recent analyst reports include a downgrade from "buy" to "hold" by Wall Street Zen and coverage initiated by Raymond James with a "market perform" rating.

Hawkins (NASDAQ:HWKN - Get Free Report) had its price target upped by equities researchers at BWS Financial from $160.00 to $200.00 in a report issued on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the specialty chemicals company's stock. BWS Financial's target price indicates a potential upside of 25.07% from the stock's current price.

Other analysts also recently issued research reports about the stock. Wall Street Zen downgraded shares of Hawkins from a "buy" rating to a "hold" rating in a research report on Saturday, July 5th. Raymond James Financial started coverage on shares of Hawkins in a research report on Thursday, July 24th. They set a "market perform" rating for the company.

Hawkins Stock Down 2.1%

Shares of HWKN traded down $3.37 during mid-day trading on Friday, reaching $159.91. 80,550 shares of the stock traded hands, compared to its average volume of 148,364. The firm has a market cap of $3.34 billion, a price-to-earnings ratio of 39.38, a P/E/G ratio of 2.71 and a beta of 0.85. The stock has a fifty day simple moving average of $145.59 and a 200 day simple moving average of $124.25. Hawkins has a 12-month low of $98.30 and a 12-month high of $171.67. The company has a quick ratio of 1.37, a current ratio of 2.15 and a debt-to-equity ratio of 0.30.

Hawkins (NASDAQ:HWKN - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $1.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.33 by $0.07. The company had revenue of $293.27 million for the quarter, compared to analyst estimates of $278.76 million. Hawkins had a net margin of 8.37% and a return on equity of 18.66%. Sell-side analysts expect that Hawkins will post 4 EPS for the current fiscal year.

Hedge Funds Weigh In On Hawkins

Hedge funds have recently added to or reduced their stakes in the business. Commonwealth Equity Services LLC boosted its holdings in shares of Hawkins by 118.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 5,603 shares of the specialty chemicals company's stock valued at $687,000 after acquiring an additional 3,034 shares during the period. KLP Kapitalforvaltning AS acquired a new position in shares of Hawkins during the fourth quarter valued at $503,000. JPMorgan Chase & Co. boosted its holdings in shares of Hawkins by 61.9% during the fourth quarter. JPMorgan Chase & Co. now owns 149,616 shares of the specialty chemicals company's stock valued at $18,353,000 after acquiring an additional 57,179 shares during the period. Alliancebernstein L.P. boosted its holdings in shares of Hawkins by 3.0% during the fourth quarter. Alliancebernstein L.P. now owns 20,284 shares of the specialty chemicals company's stock valued at $2,488,000 after acquiring an additional 592 shares during the period. Finally, B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Hawkins during the fourth quarter valued at $950,000. Institutional investors and hedge funds own 69.71% of the company's stock.

About Hawkins

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.